Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromhexine hydrochloride nebulized inhalation solution for sputum symptoms in adult lower respiratory tract infection
CTR20230078Phase 3Active
- Sponsor
- Hainan Gourd Doll Pharmaceutical Group
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bromhexine in acute bronchitis, chronic bronchitis (CB), pulmonary tuberculosis (TB), pneumoconiosis, Postoperative airway secretion retention (PASR), sponsored by Hainan Gourd Doll Pharmaceutical Group. Started Mar 2023; status: active.
02
Drugs
bromhexine
03
Conditions
acute bronchitischronic bronchitis (CB)pulmonary tuberculosis (TB)pneumoconiosisPostoperative airway secretion retention (PASR)
Beyond the preview
Go deeper on CTR20230078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230078.